Back
ProShares Ultra Nasdaq Biotechnology Vs. Direxion Daily S&P 500® Hi Bt Bl 3X ETF Industry Stock Comparison
Sell
37
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
56.87
Seasonality Move:
16.48%
Buy
84
HIBL
Direxion Daily S&P 500® Hi Bt Bl 3X ETF
Last Price:
48.97
Seasonality Move:
36.6%
Sell
37
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $56.84. The Score for BIB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- BIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
84
Direxion Daily S&P 500® Hi Bt Bl 3X ETF (HIBL)
is a Buy
Is Direxion Daily S&P 500® Hi Bt Bl 3X ETF a Buy, Sell or Hold?
- The current Direxion Daily S&P 500® Hi Bt Bl 3X ETF [HIBL] share price is $48.97. The Score for HIBL is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- HIBL is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $56.84
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing buying pressure, which is a positive indicator for future bullish movement.
HIBL Stock Price Chart
What is Direxion Daily S&P 500® Hi Bt Bl 3X ETF's stock price today?
-
The Direxion Daily S&P 500® Hi Bt Bl 3X ETF share price today is $48.97
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HIBL is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.23 | Sell |
| Relative Strength Index (14 RSI): | 40.34 | Sell |
| Chaikin Money Flow: | 6112 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.84 - 64.84) | Sell |
| Bollinger Bands (100): | (60.25 - 66.99) | Sell |
HIBL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.53 | Buy |
| Relative Strength Index (14 RSI): | 60.15 | Buy |
| Chaikin Money Flow: | 60522 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.76 - 47.48) | Buy |
| Bollinger Bands (100): | (38.08 - 46.78) | Buy |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.94 | Buy |
| 20-day SMA: | 60.43 | Sell |
| 50-day SMA: | 62.42 | Sell |
| 200-day SMA: | 59.92 | Sell |
| 8-day EMA: | 56.66 | Buy |
| 20-day EMA: | 59.27 | Sell |
| 50-day EMA: | 61.48 | Sell |
| 200-day EMA: | 60.14 | Sell |
HIBL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.34 | Buy |
| 20-day SMA: | 45.21 | Buy |
| 50-day SMA: | 44.87 | Buy |
| 200-day SMA: | 42.39 | Buy |
| 8-day EMA: | 46.13 | Buy |
| 20-day EMA: | 45.54 | Buy |
| 50-day EMA: | 44.41 | Buy |
| 200-day EMA: | 41.52 | Buy |
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Direxion Daily S&P 500® Hi Bt Bl 3X ETF Earnings Growth & HIBL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Direxion Daily S&P 500® Hi Bt Bl 3X ETF Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||